Reserpine/Hydrochlorothiazide/Vitamin B6/Calcium Pantothenate/Potassium Chloride/Dihydralazine Sulfate/Promethazine Hydrochloride/Magnesium Trisilicate/Vitamin B1

利血平/氢氯噻嗪/维生素B6/泛酸钙/氯化钾/硫酸双肼屈嗪/盐酸异丙嗪/三硅酸镁/维生素B1

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameReserpine/Hydrochlorothiazide/Vitamin B6/Calcium Pantothenate/Potassium Chloride/Dihydralazine Sulfate/Promethazine Hydrochloride/Magnesium Trisilicate/Vitamin B1

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionSynaptic vesicular amine transporter inhibitorsThiazide-sensitive sodium-chloride cotransporter inhibitorsHistamine H1 receptor antagonists +[4]

TargetsSynaptic vesicular amine transporterThiazide-sensitive sodium-chloride cotransporterHistamine H1 receptor

Therapy Area/IndicationsHypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsYes Reserpine Hydrochlorothiazide Vitamin B6

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsHypertension

Inactive IndicationsN/A

Other Information

ATC CodeC03AX01